ArticleBioengineered2022

Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway.

Zheng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.